Skip to search formSkip to main contentSkip to account menu

Ribavirin

Known as: RTCA, Ribovirin, RBV 
A synthetic nucleoside analog of ribofuranose with activity against hepatitis C virus and other RNA viruses. Ribavirin is incorporated into viral RNA… 
National Institutes of Health

Related topics

Related topics

41 relations

Narrower (12)

5'-O-galactopyranosyl ribavirinCopegusICN-1229Rebetol
Adenovirus Infections, HumanDrug AllergyHeart DiseasesHemoglobinopathies

Broader (5)

AntimetabolitesAntiviral AgentsNucleoside AnalogsReverse Transcriptase Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients.
Review
2008
Review
2008
Recent progress in the development of selected hepatitis C virus NS3.4A protease and NS5B polymerase inhibitors.
Highly Cited
2006
Highly Cited
2006
Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10… 
Highly Cited
2005
Highly Cited
2005
High‐dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C
Improved treatment regimens for patients with chronic hepatitis C, genotype 1 and high viral load are needed. Increasing the dose… 
Highly Cited
2003
Highly Cited
2003
Ribavirin Causes Error Catastrophe during Hantaan Virus Replication
ABSTRACT Except for ribavirin, no other antiviral drugs for treating hantaviral diseases have been identified. It is well… 
Highly Cited
1999
Highly Cited
1999
Recurrent and new hepatitis C virus infection after liver transplantation
Chronic infection with the hepatitis C virus (HCV) is the most common reason for liver transplantation. We examined the results… 
Highly Cited
1998
Highly Cited
1998
Oral lichen planus and HCV infection: a clinical evaluation of 263 cases
Background Hepatitis C virus (HCV) infection induces variable dermatologic manifestations. Our purpose was to determine whether… 
Highly Cited
1998
Highly Cited
1998
Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover
Treatment of patients with chronic hepatitis C with recombinant interferon alfa (rIFN‐α) can cause a decrease of serum… 
Review
1997
Review
1997
Diagnosis of hepatitis C
Currently, the second‐ and third‐generation enzyme immunoassays (EIA‐2 and EIA‐3) for hepatitis C virus antibody (anti‐HCV) are… 
Highly Cited
1992
Highly Cited
1992
Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory
Clinical and therapeutic decisions for hepatitis C virus (HCV) infection depend on factors that include documentation of past… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)